AgingResearch.NewsJoin free

Tally Health

Company

Tally Health develops 11 assets, the furthest in phase 3 (nad+ in aging). Mostly supplement and other acting on sirtuin signalling and NAD+ metabolism.

11
Assets
Furthest stage
Phase 3
Raised
US$10m
0
Trials
0
Signals

Pipeline

11

  • nad+

    Niacinamide is converted into NAD+ to support cellular energy production and DNA repair.

    Phase 3, Supplement, Sirtuin signalling, NAD+ metabolism, aging, healthspan improvement

  • Amplify

    Increases NAD+ and optimizes mitochondrial function to support metabolism and cellular energy.

    Stage not known, Supplement

  • Cognitive Lift

    Stage not known, Supplement

8 more assets

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms3
  • Funding rounds and grants1
  • People4
  • Signals1
  • Similar companies6

Intelligence